Lv2
180 积分 2024-08-26 加入
Differential BET Bromodomain Inhibition by Dihydropteridinone and Pyrimidodiazepinone Kinase Inhibitors
10小时前
待确认
Design, synthesis, and biological evaluation of novel molecules as potent inhibitors of PLK1
14小时前
已完结
Structure-Based Discovery of a Highly Selective, Oral Polo-Like Kinase 1 Inhibitor with Potent Antileukemic Activity
17小时前
已完结
Polo-like Kinase 1 Inhibitors in Human Cancer Therapy: Development and Therapeutic Potential
18小时前
已完结
Direct deaminative functionalization with N-nitroamines
3天前
已完结
First-Line Sacituzumab Govitecan Plus Pembrolizumab in Metastatic NSCLC: PD-L1 TPS <50% and ≥50% Cohorts of the EVOKE-02 Study
3天前
已完结
Poly(carboxybetaine) lipids enhance mRNA therapeutics efficacy and reduce their immunogenicity
4天前
已完结
Zwitterionic materials for nucleic acid delivery and therapeutic applications
4天前
已完结
Zwitterionic Biomaterials
5天前
已完结
Zwitterionic Peptides: From Mechanism, Design Strategies to Applications
5天前
已完结
皖公网安备34019202002308
